Page last updated: 2024-08-23

idazoxan and Amentia

idazoxan has been researched along with Amentia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenup, JL; Leverenz, JB; Peskind, ER; Raskind, MA; Szot, P; White, SS1
Coull, JJ; Hodges, JR; Sahakian, BJ1
Coull, JT; Hodges, JR; Sahakian, BJ1
Conway, SC; Ebmeier, KP; Glabus, MF; Goodwin, GM; O'Carroll, RE; Peyro-Saint-Paul, H1
Robles BayĆ³n, A1
Ghika, J; Growdon, J; Hoffman, E; Schoenfeld, D; Tennis, M1

Trials

3 trial(s) available for idazoxan and Amentia

ArticleYear
The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.
    Psychopharmacology, 1996, Volume: 123, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Attention; Cognition; Dementia; Female; Frontal Lobe; Humans; Idazoxan; Male; Middle Aged

1996
Executive function and uptake of 99mTc-exametazime shown by single photon emission tomography after oral idazoxan in probable Alzheimer-type dementia.
    Psychopharmacology, 1997, Volume: 131, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Brain; Cognition; Dementia; Female; Humans; Idazoxan; Male; Neuropsychological Tests; Perfusion; Tomography, Emission-Computed, Single-Photon

1997
Idazoxan treatment in progressive supranuclear palsy.
    Neurology, 1991, Volume: 41, Issue:7

    Topics: Adrenergic alpha-Antagonists; Aged; Dementia; Depression; Dioxanes; Female; Gait; Humans; Idazoxan; Male; Movement; Severity of Illness Index; Supranuclear Palsy, Progressive

1991

Other Studies

3 other study(ies) available for idazoxan and Amentia

ArticleYear
Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes.
    Neuroscience, 2007, Apr-25, Volume: 146, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Dementia; Female; Gene Expression Regulation; Humans; Idazoxan; Male; Middle Aged; Postmortem Changes; Prazosin; Prefrontal Cortex; Receptors, Adrenergic; RNA, Messenger

2007
Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:1

    Topics: Administration, Oral; Cognition; Dementia; Dioxanes; Double-Blind Method; Frontal Lobe; Humans; Idazoxan; Male; Placebos; Receptors, Adrenergic, alpha; Treatment Outcome; Verbal Behavior

1994
[Frontotemporal dementia: therapeutic possibilities].
    Neurologia (Barcelona, Spain), 2000, Volume: 15 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Dementia; Frontal Lobe; Humans; Idazoxan; Primary Health Care; Temporal Lobe

2000